Effect of vaginal lactobacillus suppository on in-vitro fertilization (IVF) results
Phase 3
Recruiting
- Conditions
- Female infertility.Female infertility of uterine originN97.2
- Registration Number
- IRCT20230718058835N2
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Age less than 40 years
Maximum FSH level of 15 IU/ml
Absence of any systemic diseases (hypertension, diabetes, antiphospholipid syndrome, lupus, thrombophilia and thyroid diseases)
Normal uterine cavity with sufficient endometrial thickness of 7 mm
Absence of hydrosalpinx
Exclusion Criteria
Diagnosis of Asherman's syndrome
Diagnosis of polyps and fibroids by hysteroscopy
Refusal to participate in the study
Presence of chronic disease
The presence of vaginal infectious discharge
Receiving medical treatment chronically
Repeated IVF failure (more than 3 times in previous cycles)
Presence of clinical symptoms of vaginal infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy rate. Timepoint: Two weeks after embryo transfer. Method of measurement: Serum level of ß-HCG.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy rate. Timepoint: 4-6 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.